Beck Mack & Oliver’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $37.1K | Hold |
7,000
| – | – | ﹤0.01% | 183 |
|
2025
Q1 | $31K | Hold |
7,000
| – | – | ﹤0.01% | 182 |
|
2024
Q4 | $49K | Hold |
7,000
| – | – | ﹤0.01% | 183 |
|
2024
Q3 | $102K | Buy |
7,000
+4,000
| +133% | +$58K | ﹤0.01% | 170 |
|
2024
Q2 | $219K | Hold |
3,000
| – | – | ﹤0.01% | 164 |
|
2024
Q1 | $178K | Hold |
3,000
| – | – | ﹤0.01% | 169 |
|
2023
Q4 | $220K | Hold |
3,000
| – | – | 0.01% | 168 |
|
2023
Q3 | $117K | Hold |
3,000
| – | – | ﹤0.01% | 161 |
|
2023
Q2 | $173K | Hold |
3,000
| – | – | ﹤0.01% | 166 |
|
2023
Q1 | $195K | Hold |
3,000
| – | – | 0.01% | 162 |
|
2022
Q4 | $82.5K | Hold |
3,000
| – | – | ﹤0.01% | 167 |
|
2022
Q3 | $88K | Hold |
3,000
| – | – | ﹤0.01% | 164 |
|
2022
Q2 | $58K | Buy |
3,000
+2,000
| +200% | +$38.7K | ﹤0.01% | 168 |
|
2022
Q1 | $81K | Hold |
1,000
| – | – | ﹤0.01% | 186 |
|
2021
Q4 | $92K | Hold |
1,000
| – | – | ﹤0.01% | 199 |
|
2021
Q3 | $125K | Hold |
1,000
| – | – | ﹤0.01% | 209 |
|
2021
Q2 | $113K | Hold |
1,000
| – | – | ﹤0.01% | 197 |
|
2021
Q1 | $152K | Hold |
1,000
| – | – | ﹤0.01% | 183 |
|
2020
Q4 | $115K | Hold |
1,000
| – | – | ﹤0.01% | 192 |
|
2020
Q3 | $77K | Hold |
1,000
| – | – | ﹤0.01% | 186 |
|
2020
Q2 | $110K | Hold |
1,000
| – | – | ﹤0.01% | 185 |
|
2020
Q1 | $109K | Hold |
1,000
| – | – | ﹤0.01% | 177 |
|
2019
Q4 | $159K | Hold |
1,000
| – | – | 0.01% | 206 |
|
2019
Q3 | $148K | Hold |
1,000
| – | – | 0.01% | 200 |
|
2019
Q2 | $116K | Hold |
1,000
| – | – | ﹤0.01% | 211 |
|
2019
Q1 | $108K | Hold |
1,000
| – | – | ﹤0.01% | 214 |
|
2018
Q4 | $82K | Buy |
+1,000
| New | +$82K | ﹤0.01% | 212 |
|